Progress and prospects in hepatocellular carcinoma surgery

Annales de Chirurgie

Volumn 52, Issue 6, 1998, Pages 558-563

  Tang, Z Y ^a   Yu, Y Q ^a   Zhou, X D ^a   Ma, Z C ^a   Wu, Z Q ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Cytoreductive therapy; Hepatocellular carcinoma; Second stage resection

Indexed keywords

ALPHA FETOPROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; INTEGRIN; PROTEIN P16; PROTEIN P21; PROTEIN P53; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CHINA; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ONCOGENE C ERB; REOPERATION; SCHOOL CHILD; SURVIVAL RATE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CHINA; DISEASE MODELS, ANIMAL; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MICE; MICE, NUDE; PALLIATIVE CARE; REOPERATION; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0031874398     PISSN: 00033944     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)